Work

Role of mTOR As an Essential Kinase in SCLC

Year: 2020

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2020.05.026

Authors: Jeffrey A. Kern, Jihye Kim, Daniel G. Foster, Rangnath Mishra, Eric E. Gardner, John T. Poirier, Christopher Rivard, Hui Yu, James H. Finigan, Afshin Dowlati, Charles M. Rudin, Aik-Choon Tan

Institutions: National Jewish Health, University of Colorado Denver, Memorial Sloan Kettering Cancer Center, NYU Langone’s Laura and Isaac Perlmutter Cancer Center, New York University, Case Western Reserve University, Moffitt Cancer Center

Language: English

Topic: Lung Cancer Research Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Eli Lilly and Company, GlaxoSmithKline, Roche, National Cancer Research Institute, Cancer League of Colorado, David F. and Margaret T. Grohne Family Foundation, EMD Serono, Cancer Center, University of Colorado, National Heart, Lung, and Blood Institute, National Cancer Institute

Awards: G1565180698, G2988872836, G3117500281, Kinase Dependent Chemotherapy Resistance Mechanisms in Small Cell Lung Cancer, G4651258030, ADAM17-NRG-1 Signaling in Acute Lung Injury, G7568390853, SPORE in Lung Cancer, Cancer Center Support Grant, University of Colorado Cancer Center Support Grant

OpenAlex ID: W3037626944

FWCI: 1.043

Cites: 52

Cited by: 20

Related to: 10